MedPath

Effectiveness of a Psychoeducational Group Intervention in Patients With Depression and Physical Comorbidity

Not Applicable
Conditions
Depressive Disorder
Registration Number
NCT03243799
Lead Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Brief Summary

The primary aim is to evaluate the effectiveness of an intervention based on a psychoeducational program carried out by primary care nurses, to improve the rate of remission and response of depression in patients with physical chronic illness (diabetes, COPD, asthma and / or ischemic heart disease). Secondarily, to assess the cost-effectiveness of the intervention, the effectiveness to improve the control of physical pathology, the impact on quality of life and the feasibility of the intervention.

Methods: a multicentre, randomized clinical trial, with two groups and 1 year follow-up evaluation. Economic evaluation study. We will study 504 patients (252 in each group), over 50 years assigned to 25 primary care teams (PC) from Catalonia (urban, semi-urban and rural) with major depression and with at least one of the diseases: diabetes mellitus type 2, chronic obstructive pulmonary disease, asthma, and / or ischemic heart disease. They will be distributed randomly into two groups. The intervention group will participate in psychoeducational groups: 12 weekly 90-minute sessions led by two nurses from PC, consisting of health education on chronic physical illness and depressive symptoms.

Main measurements: clinical remission of depression and / or response to intervention (Beck depression inventory: BDI-II). Secondary measures: improvement in control of chronic disease (blood test and physical parameters), drug compliance (test Morinsky-Green and number of packaging), quality of life (EQ-5D), medical service utilization (appointments and hospital admissions due to complications) and feasibility of the intervention (satisfaction and compliance). Evaluations will be masked and conducted at 0, 3 and 12 months. At 6 months, patients will receive a call from nurses.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
504
Inclusion Criteria
  • Presence of at least one of the following diseases: type 2 diabetes mellitus, chronic obstructive pulmonary disease, asthma, and / or ischemic heart disease.
  • Meet major depression criteria at the time of the study: Score above 13 on the BDI-II scale.
  • Possibility of follow-up of one year by the same primary care team.
  • At least read and write Spanish or Catalan.
Exclusion Criteria
  • Diagnosis of dementia or moderate or high cognitive impairment (5 or more errors according to the pfeiffer scale).
  • Major depression with psychotic symptoms or with other serious psychiatric comorbidities.
  • Moderate or high risk of suicide (6 or more points on the MINI suicide scale).
  • Dependency disorders due to alcohol or other drug abuse.
  • Advanced stage physical disease.
  • Inability to travel to the center.
  • Be receiving some psychological therapy by the Center of mental health (CSM) of reference

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Changes in rate of remission of depressionAt 12 months of follow-up

Changes in the score of the BDI-II scale

Secondary Outcome Measures
NameTimeMethod
Changes in rate of remission of depressionAt 3 months of follow-up

Changes in the score of the BDI-II scale

Changes in the control of asthmaAt 12 months of follow-up

Changes in FEV1

Changes in the control of Ischemic heart diseaseAt 12 months of follow-up

Changes in LDL cholesterol

Satisfaction with the interventionAt 3 months of follow-up

Survey at the end of the intervention

Adherence to the interventionAt 3 months of follow-up

Number of assisted sessions

Quantification of the use of servicesAt 12 months of follow-up

Number of hospital admissions

Qualitative changes of the state of health at the end of the interventionAt 3 and 12 months of follow-up

better, equal or worse

Changes in the control of DM2At 12 months of follow-up

Changes in HbA1c

Record of therapeutic complianceAt 12 months of follow-up

Morisky-Green test

Referrals to mental healthAt 12 months of follow-up

Number of visits to mental health centers

Changes in the quality of lifeAt 12 months of follow-up

Measured by the EuroQol scale (EQ-5D)

Qualitative changes of the state of mind at the end of the interventionAt 3 and 12 months of follow-up

better, equal or worse

Changes in the control of COPDAt 12 months of follow-up

Changes in FEV1

Trial Locations

Locations (1)

Centre d'Atenció Primària (CAP) Santa Margarida de Montbui

🇪🇸

Santa Margarida de Montbui, Barcelona, Spain

Centre d'Atenció Primària (CAP) Santa Margarida de Montbui
🇪🇸Santa Margarida de Montbui, Barcelona, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.